Molecure S.A. (WSE:MOC)
Poland flag Poland · Delayed Price · Currency is PLN
8.39
+0.01 (0.12%)
May 13, 2025, 3:55 PM CET

Molecure Revenue

Molecure had revenue of 602.75K PLN in the quarter ending March 31, 2025, with 2,019.51% growth. This brings the company's revenue in the last twelve months to 3.49M, up 80.28% year-over-year. In the year 2024, Molecure had annual revenue of 2.92M, down -20.08%.

Revenue (ttm)
3.49M
Revenue Growth
+80.28%
P/S Ratio
48.51
Revenue / Employee
34.22K
Employees
102
Market Cap
169.30M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20242.92M-733.54K-20.08%
Dec 31, 20233.65M-3.86M-51.39%
Dec 31, 20227.51M6.35M543.32%
Dec 31, 20211.17M-123.74M-99.07%
Dec 31, 2020124.91M122.90M6,100.72%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
NEUCA 12.61B
Synektik Spólka Akcyjna 556.63M
Voxel 507.77M
Celon Pharma 209.54M
Ryvu Therapeutics 101.96M
Selvita 345.76M
Centrum Medyczne ENEL-MED 735.59M
EMC Instytut Medyczny 809.41M
Revenue Rankings